Anlon Healthcare Shares Make Flat Debut on Stock Market, List at 1.10% Premium

Anlon Healthcare Ltd, which launched its Initial Public Offering (IPO) on August 26, 2025 made its debut on Dalal Street today on September 3, 2025. The shares of Anlon Healthcare Limited made a muted debut, listing at only 1.10% premium over the issue price.

The shares opened at ₹91 on the BSE, marking  flat listing at 0% premium over the IPO upper price band of ₹91. On NSE, the shares of  Anlon Healthcare opened at ₹92, marking a discount of 1.10%. After the listing, the shares fell around 0.6% from the listing price to ₹91.4.

Ahead of its listing, the shares of Anlon Healthcare Ltd were trading almost flat at ₹92, marking a Grey Market Premium (GMP) of ₹1 or 1.1%. 

Anlon Healthcare  IPO Overall Subscription Status

[29 August, 2025, End of the day]

Anlon Healthcare Ltd - Business Overview

Anlon Healthcare Limited, incorporated in 2013 and based in Rajkot, is a chemical manufacturing company specializing in high-purity pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Its offerings include pharmaceutical formulations, nutraceuticals, personal care, and veterinary products. The company has 65 commercial products, with several more under pilot and lab stages.

Financially, the company reported a revenue of ₹120.46 crore in FY25, up from ₹66.69 crore in FY24, while, Profit After Tax (PAT) increased to ₹20.52 crore. Total assets rose to ₹181.30 crore, reflecting expansion and improved operational efficiency.

Explore other Upcoming IPOs on BSE and NSE.

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here.